Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pycnogenol in People With Post-COVID-19 Condition
NCT05890534Phase 3Completed
- Sponsor
- University of Zurich
- Start
- Jun 2023
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of grape seed extract in post-COVID-19 condition (PCC), sponsored by University of Zurich. Started Jun 2023; status: completed.
02
Drugs
grape seed extract
03
Conditions
post-COVID-19 condition (PCC)
Beyond the preview
Go deeper on NCT05890534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05890534.